Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5983_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
12.10.2026
Размер:
6 Мб
Скачать
☆
248
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2

8.2.1 POLYMER SOLUTION CONCENTRATION AND VISCOSITY







        

-
tration plays an important role. Whereas the viscosity also plays a great





8.2.2 MOLECULAR WEIGHT OF POLYMER

        





-
tion (Haghi and Akbari, 2007).

8.2.3 SURFACE TENSION



   


8.2.4 ELECTRICAL CONDUCTIVITY




Nanofiber Technology in Biomedical Applications
249

         




Mit-uppatham et al., 2004).

8.2.5 APPLIED VOLTAGE

        







8.2.6 FEED RATE/FLOW RATE


    





8.2.7 TEMPERATURE AND HUMIDITY

         



       


al., 2013).
250
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2

8.3 METHOD OF PREPARATION FOR NANOFIBERS

8.3.1 ELECTROSPINNING



-

        



        

 

   




      
      
     
  






al., 2009).

8.3.2 SELF-ASSEMBLY

        

      

Nanofiber Technology in Biomedical Applications
251


    -
amine and its deacetylated derivative. Here the individual components

       
    
ranging in nanometers than the electrospinning technique (Jayaraman et


et al., 2003).

8.3.3 PHASE SEPARATION

     


-

FIGURE 8.1 
252
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
    


       
-
   

Ramakrishna, 2005).
FIGURE 8.2 

8.3.4 DRAWING OF NANOFIBERS

-




        




et al., 2011).
Nanofiber Technology in Biomedical Applications
253
FIGURE 8.3 

8.3.5 TEMPLATE SYNTHESIS


structure. Generally nanoporous metal oxide membranes such as aluminum
          
       


8.4 BIOMEDICAL APPLICATIONS OF NANOFIBERS

        

254
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
TABLE 8.1 
Biomedical
application
System name Drug used Polymer used References
Wound
dressing
Electrospun

Cloxacillin PLA and poly(butylene
adipate-co-terephthalate)

Schneider et
al., 2018
Electrospun


acetate
CS and PVA Abbaspour
et al., 2015

engineering
Electrospun
polymeric

NA Cellulose acetate and
iron acetate
Mousa et al.,
2021
Electrospun

NA PCL and CS Semnani et
al., 2017
Cancer
therapy
Electrospun

5-Fluorouracil PCL and CS 
al., 2018
Electrospun

Paclitaxel PLGA and CS 
2020
FIGURE 8.4 
Nanofiber Technology in Biomedical Applications
255

8.4.1 WOUND DRESSING




         
          

-

have been introduced incorporating various antibiotics that are required

       

          
  
        

  
         




        
-

   


Staphylococcus aureus
          
concluded that the prepared cloxacillin-loaded biocompatible electrospun






256
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2


enhanced antimicrobial activity against Pseudomonas aeruginosa and S.
aureus
      

al., 2015).

8.4.2 TISSUE ENGINEERING

   
  

    
skin, bone, dentin, collagen, and liver. Both natural and synthetic

possess the ability to repair, replace, and regenerate the required tissues,


nature, high quality mechanical properties, high porosity, ability to
  


         

      
osteoblastic adhesion, and extracellular matrix secretion on the carbon

 -

   

         -


(Eatemadi et al., 2016).


Nanofiber Technology in Biomedical Applications
257

      -
    
  
    
      

 

   
(Mousa et al., 2021).
        -
      

-

  




  
the cells (Semnani et al., 2017).

8.4.3 IN CANCER THERAPY

        

       
healthy tissue, and a high removal rate by the reticuloendothelial system.
        
has the potential to rule out the various disadvantages and it also can be


      -
            
drugs such as dichloroacetate, cisplatin, paclitaxel, and doxorubicin can
       